A regulatory structure for working with genetically modified mosquitoes: lessons from Mexico

  Community approval was necessary for INSP to acquire land for the trial, and part of the deliberative process prior to granting permission was for the INSP and the Project to communicate its intentions for initial as well as potential future use. [...]the asamblea ejidal was an integrating entity...

Full description

Saved in:
Bibliographic Details
Published in:PLoS neglected tropical diseases 2014-03, Vol.8 (3), p.e2623-e2623
Main Authors: Ramsey, Janine M, Bond, J Guillermo, Macotela, Maria Elena, Facchinelli, Luca, Valerio, Laura, Brown, David M, Scott, Thomas W, James, Anthony A
Format: Article
Language:English
Subjects:
Animals
Biotechnology industry
Culicidae - genetics
Culicidae - growth & development
Decision making
Disease
Disease prevention
Disease Vectors
Genetic aspects
Genetically modified organisms
Health aspects
Health Policy
Humans
Laws, regulations and rules
Medicine
Mexico
Mosquito Control - methods
Mosquito Control - standards
Mosquitoes
Organisms, Genetically Modified
Pest Control, Biological - methods
Pest Control, Biological - standards
Policy Platform
Product development
Public health
Science Policy
Studies
Technological change
Vector control
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:  Community approval was necessary for INSP to acquire land for the trial, and part of the deliberative process prior to granting permission was for the INSP and the Project to communicate its intentions for initial as well as potential future use. [...]the asamblea ejidal was an integrating entity for all regulatory components at the local level. Add to this the global nature of such a project, with financing and stakeholders having multiple national, cultural, scientific, and institutional experiences, norms, and perspectives, and the testing of a novel genetic-based technology can quickly become a complex process. [...]a project designed to test the public health potential of genetically modified products requires careful attention at all levels to continuous, open, and proactive communication.
ISSN:1935-2735
1935-2727
1935-2735
DOI:10.1371/journal.pntd.0002623